Pfizer Inc
NYSE: PFE
$28.46
-$0.40 (-1.4%)
Closing Price on October 29, 2024
PFE Articles
Pfizer announced the results from its first two pivotal Phase 3 studies from the Oral Clinical Trials for tofacitinib in ulcerative colitis program at the 11th Congress of European Crohn's and...
Published:
Last Updated:
So what are investors to do in a continued low rate environment? Buy the best stocks out there, especially ones paying good dividends.
Published:
Last Updated:
One analyst firm believes the development of abuse-deterrent formulations (ADF) of opioids creates a risk that older non-ADFs may be removed from the market, creating a huge risk and opportunity in...
Published:
Last Updated:
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
Published:
Last Updated:
March 11, 2016: Markets opened higher again on Friday and held on to the early gains all day. Energy and financials stocks led the gainers and only 2 of 10 sectors posted losses: consumer staples and...
Published:
Last Updated:
24/7 Wall St. screened the Merrill Lynch research data base for solid growth ideas that also paid a dividend of at least 4%.
Published:
Last Updated:
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
Published:
Last Updated:
Most of the stocks traded on the New York Stock Exchange with the greatest number of shares short saw their short interest decline between the February 12 and February 29 settlement dates.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday, March 8, include AutoNation, Celldex Therapeutics, EP Energy, Shopify, Sony, Urban Outfitters and Valeant Pharmaceuticals.
Published:
Last Updated:
So far this year, based on changes in yields, the Dogs of the Dow are doing much better, as their yields have not widened out near as much as the other 20 Dow companies.
Published:
Last Updated:
February 29, 2016: Markets opened lower on Monday before rising to intra-day highs at around noon, and then dipping to a loss by mid-afternoon. Healthcare and energy stocks were the biggest losers...
Published:
Last Updated:
With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these four are outstanding.
Published:
Last Updated:
February 26, 2016: Markets opened higher on Friday on rising oil prices in Asia and Europe which turned into lower prices as the trading day went along. Basic materials and financials were today’s...
Published:
Last Updated:
For the long haul, these three stock should provide a much better avenue for total return and continue to increase dividend payouts.
Published:
Last Updated:
The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
Published:
Last Updated: